Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania
Open Access
- 11 February 2013
- journal article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 12 (1), 60
- https://doi.org/10.1186/1475-2875-12-60
Abstract
Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. Recently, there was an anecdotal report on high malaria recurrence rate following AL treatment in in the (urban and peri-urban), western part of Tanzania. The current report is an exploratory study to carefully and systematically assess AL efficacy in the area. Between June and August 2011, a total of 1,126 patients were screened for malaria, 33 had malaria, of which 20 patients met inclusion criteria and were enrolled and treated with standard dose of AL as recommended in the WHO protocol. Treated patients were followed up for 28 days to assess treatment responses. Before treatment (Day 0) and post-treatment (Day 7) plasma lumefantrine levels were determined to assess prior AL use and ascertain parasites exposure to adequate plasma leveles of lumefantrine, respectively. The cure rate was 100%. All Day 0 plasma lumefantrine were below HPLC detectable level. The median Day 7 lumefantrine concentration was 404, (range, 189–894 ng/ml). Six out of 20 patients (30%) were gametocytaemic and all cleared gametocytes by Day 14. One patient showed an increase in gametocytes from four on Day 0 to 68, per 500 WBC on Day 2. Artemether lumefantrine is highly efficacious against uncomplicated Plasmodium falciparum malaria. The elevation of gametocytaemia despite AL treatment needs to be evaluated in a larger study.Keywords
This publication has 33 references indexed in Scilit:
- A Major Genome Region Underlying Artemisinin Resistance in MalariaScience, 2012
- In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central EthiopiaMalaria Journal, 2011
- Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar borderMalaria Journal, 2010
- Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugsMalaria Journal, 2010
- Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistanceMalaria Journal, 2009
- Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and EthiopiaMalaria Journal, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaThe New England Journal of Medicine, 2009
- Malaria misdiagnosis in Uganda – implications for policy changeMalaria Journal, 2009
- Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaMalaria Journal, 2007
- Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalMalaria Journal, 2007